Variants in FAM13A are associated with chronic obstructive pulmonary disease
Michael H. Cho(Brigham and Women's Hospital), Edwin K. Silverman(Brigham and Women's Hospital), Elizabeth A. Regan(National Jewish Health), Gary M. Hunninghake(Brigham and Women's Hospital), Terri H. Beaty(Johns Hopkins University), Xiangyang Kong(GlaxoSmithKline (United Kingdom)), Wayne H. Anderson(University of North Carolina at Chapel Hill), Ruth Tal‐Singer, Nadia Boutaoui(Children's Hospital of Pittsburgh), James D. Crapo(National Jewish Health), Dawn L. DeMeo(Brigham and Women's Hospital), Barry J. Make(National Jewish Health), Per Bakke(University of Bergen), John E. Hokanson(University of Colorado Anschutz Medical Campus), Craig P. Hersh(Brigham and Women's Hospital), Amund Gulsvik(University of Bergen), David Sparrow(Boston University), Barbara J. Klanderman(Harvard University), Augusto A. Litonjua(Outcomes Research Consortium), Sungho Won(Seoul National University), Sreekumar Pillai(GlaxoSmithKline (United States)), James R. Murphy(University of Liverpool), Jody Sylvia, John Ziniti(Brigham and Women's Hospital), David A. Lomas(University of Cambridge), Christoph Lange(Harvard University)
Cited by 423
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2013|3.8k
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
|New England Journal of Medicine|2010|3k
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
|The Lancet|2007|2.4k
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k